Precision Business Insights
Portfolio

 

Research Reports

Immunotherapy Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Immunotherapy Drugs Market: By Drugs (Vaccines (Preventive Vaccines, Therapeutic Vaccines), Monoclonal Antibodies, Interferons Alpha & Beta, Checkpoint Inhibitors, Interleukins, and Others), By Therapy Area (Autoimmune & Inflammatory Diseases, Cancer, Infectious Diseases, and Others), By End User (Hospitals/Clinics, Cancer Research Centre, and Others), and Geography

 

 

Global Immunotherapy Drugs Market:

The global immunotherapy drugs market estimated to be valued US$ XX. Mn in 2018 and poised to grow at significant CAGR over 2019-2025 due to surge in the prevalence of chronic diseases. According to International Agency for Research on Cancer (IACR) in 2018, 18.1 Mn people are estimated to be suffering from cancer worldwide, which is expected to reach 29.5 Mn by 2040. Moreover, rising demand and development of monoclonal antibodies (mAbs) and emergence of biosimilars are the major factors that are driving the growth of the immunotherapy drugs market. Additionally, favorable reimbursement policies and support by the government fuels the growth of the market. However, High cost of treatment for chronic diseases hinders the growth of the market over forecast period.

Increase in the Prevalence of Chronic Diseases and Emergence of Biosimilars into the market  

Rising adoption of targeted therapies and quick drug approval processes and rising prevalence rate of lifestyle diseases drives the growth of the market for Immunotherapy drugs. Cancer segment is the fastest growing segment by therapy area owing to increasing prevalence of cancer and the preference of immunotherapy as the first line of treatment for cancer. Rising demand for monoclonal antibodies and development of monoclonal antibodies coupled with the emergence of new biosimilars into the market enhances the growth of the market.

North America Accounts for Larger Market Revenue Share in Global Immunotherapy Drugs Market

North America accounted for larger revenue share in global immunotherapy drugs market with significant CAGR owing to presence of large number of market players and development and launch of new molecules into the market. Asia Pacific region is expected to be the fastest growing region over the forecast period due to acceptable regulatory scenario in the region and low cost of drug manufacturing attributes to the growth of the market. Europe market is expected to show the significant growth rate over the forecast years.

Competition Assessment

Key player’s profiles in the global immunotherapy drugs market include:

  • AbbVie Inc. (U.S.)
  • Amgen Inc. (U.S.)
  • AstraZeneca plc. (U.K.)
  • Bristol-Myers Squibb (U.S.)
  • Hoffmann-La Roche AG (Switzerland)
  • GlaxoSmithKline plc (U.K.)
  • Johnson & Johnson (U.S.)
  • Merck & Co., Inc (U.S.)
  • Novartis AG (Switzerland)
  • Eli Lilly & Co. (U.S.)

 

 

Global immunotherapy drugs market is surging owing to strategic collaborations and definitive agreements between the market players to develop and commercialize product in the market. For instance, In March 2018, Inovio collaborated with ApolloBio Corp, and provided exclusive right to develop, manufacture and commercialize VGX-3100, a DNA immunotherapy, in greater China. In March 2018, Novartis collaborated with Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute for developing next generation biomaterials systems to deliver immune-oncology therapies.

Key Findings of the Report:

 

  • Global immunotherapy drugs market expanding at significant CAGR over 2018 to 2024 owing to rising demand for monoclonal antibodies and emergence of biosimilars coupled with increase in prevalence of chronic diseases.
  • Based on therapy area, cancer segment immunotherapy drugs accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global immunotherapy drugs market

 

Global Immunotherapy Drugs Market Report Description:

 

Global immunotherapy drugs market report gives comprehensive outlook on immunotherapy drugs across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global immunotherapy drugs market gives historical, current, and future market sizes (US$ Mn) on the basis of drugs type, therapy area, end user, and region. This report studies global immunotherapy drugs market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global immunotherapy drugs market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global immunotherapy drugs market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global immunotherapy drugs market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global immunotherapy drugs products.

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

 

By Drugs

  • Vaccines
    • Preventive Vaccines
    • Therapeutic Vaccines
  • Monoclonal Antibodies
  • Interferons Alpha & Beta
  • Checkpoint Inhibitors
  • Interleukins
  • Others

By Therapy Area

  • Autoimmune & Inflammatory Diseases
  • Cancer
  • Infectious Diseases
  • Others

By End User

  • Hospitals/Clinics
  • Cancer Research Centers
  • Others

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA
  1. Executive Summary
  2. Global Immunotherapy Drugs Market Introduction

2.1. Global Immunotherapy Drugs Market – Taxonomy

2.2. Global Immunotherapy Drugs Market –Definitions

2.2.1. By Drugs

2.2.2. By Therapy Area

2.2.3. By End User

  1. Global Immunotherapy Drugs Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Immunotherapy Drugs Market Dynamics – Factors Impact Analysis

  1. Global Immunotherapy Drugs Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

  1. Global Immunotherapy Drugs Market Forecast, By Drugs, 2014 – 2018 and Forecast, 2019 – 2025

5.1. Vaccines

5.1.1. Preventive Vaccines

5.1.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.1.3. Market Opportunity Analysis

5.1.2. Therapeutic Vaccines

5.1.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.3. Market Opportunity Analysis

5.2. Monoclonal Antibodies

5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Interferons Alpha & Beta

5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Checkpoint Inhibitors

5.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Interleukins

5.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

5.6. Others

5.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.6.3. Market Opportunity Analysis

  1. Global Immunotherapy Drugs Market Forecast, By Therapy Area, 2014 – 2018 and Forecast, 2019 – 2025

6.1. Autoimmune & Inflammatory Diseases

6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Cancer

6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Infectious Diseases

6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Others

6.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

  1. Global Immunotherapy Drugs Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025

7.1. Hospitals/Clinics

7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Cancer Research Centers

7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Others

7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

  1. Global Immunotherapy Drugs Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025

8.1. North America

8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific

8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. The Middle East & Africa

8.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Immunotherapy Drugs Market – Opportunity Analysis Index, By Drugs, By Therapy Area, By End User, and Region, 2019 – 2025

  1. North America Immunotherapy Drugs Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

9.1. Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Vaccines

9.1.1.1. Preventive Vaccines

9.1.1.2. Therapeutic Vaccines

9.1.2. Monoclonal Antibodies

9.1.3. Interferons Alpha & Beta

9.1.4. Checkpoint Inhibitors

9.1.5. Interleukins

9.1.6. Others

9.2. Therapy Area Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.2.1. Autoimmune & Inflammatory Diseases

9.2.2. Cancer

9.2.3. Infectious Diseases

9.2.4. Others       

9.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.3.1. Hospitals/Clinics

9.3.2. Cancer Research Centers

9.3.3. Others

9.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. U.S.

9.4.2. Canada

9.5. North America Immunotherapy Drugs Market – Opportunity Analysis Index, By Drugs, By Therapy Area, By End User, and Country, 2019 – 2025

9.6. North America Immunotherapy Drugs Market Dynamics – Trends

  1. Europe Immunotherapy Drugs Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

10.1. Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Vaccines

10.1.1.1. Preventive Vaccines

10.1.1.2. Therapeutic Vaccines

10.1.2. Monoclonal Antibodies

10.1.3. Interferons Alpha & Beta

10.1.4. Checkpoint Inhibitors

10.1.5. Interleukins

10.1.6. Others

10.2. Therapy Area Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Autoimmune & Inflammatory Diseases

10.2.2. Cancer

10.2.3. Infectious Diseases

10.2.4. Others       

10.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.3.1. Hospitals/Clinics

10.3.2. Cancer Research Centers

10.3.3. Others

10.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. U.K.

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Russia

10.4.7. Rest of Europe

10.5. Europe Immunotherapy Drugs Market – Opportunity Analysis Index, By Drugs, By Therapy Area, By End User, and Country, 2019 – 2025

10.6. Europe Immunotherapy Drugs Market Dynamics – Trends

  1. Asia Pacific Immunotherapy Drugs Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

11.1. Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Vaccines

11.1.1.1. Preventive Vaccines

11.1.1.2. Therapeutic Vaccines

11.1.2. Monoclonal Antibodies

11.1.3. Interferons Alpha & Beta

11.1.4. Checkpoint Inhibitors

11.1.5. Interleukins

11.1.6. Others

11.2. Therapy Area Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Autoimmune & Inflammatory Diseases

11.2.2. Cancer

11.2.3. Infectious Diseases

11.2.4. Others       

11.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.3.1. Hospitals/Clinics

11.3.2. Cancer Research Centers

11.3.3. Others

11.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. ASEAN Counties

11.4.5. Philippines

11.4.6. Rest of Asia Pacific

11.5. Asia Pacific Immunotherapy Drugs Market – Opportunity Analysis Index, By Drugs, By Therapy Area, By End User, and Country, 2019 – 2025

11.6. Asia Pacific Immunotherapy Drugs Market Dynamics – Trends

  1. Latin America Immunotherapy Drugs Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

12.1. Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Vaccines

12.1.1.1. Preventive Vaccines

12.1.1.2. Therapeutic Vaccines

12.1.2. Monoclonal Antibodies

12.1.3. Interferons Alpha & Beta

12.1.4. Checkpoint Inhibitors

12.1.5. Interleukins

12.1.6. Others

12.2. Therapy Area Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Autoimmune & Inflammatory Diseases

12.2.2. Cancer

12.2.3. Infectious Diseases

12.2.4. Others       

12.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Hospitals/Clinics

12.3.2. Cancer Research Centers

12.3.3. Others

12.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Mexico

12.4.2. Brazil

12.4.3. Argentina

12.4.4. Chile

12.4.5. Rest of Latin America

12.5. Latin America Immunotherapy Drugs Market – Opportunity Analysis Index, By Drugs, By Therapy Area, By End User, and Country, 2019 – 2025

12.6. Latin America Immunotherapy Drugs Market Dynamics – Trends

  1. Middle East and Africa Immunotherapy Drugs Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

13.1. Drugs Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Vaccines

13.1.1.1. Preventive Vaccines

13.1.1.2. Therapeutic Vaccines

13.1.2. Monoclonal Antibodies

13.1.3. Interferons Alpha & Beta

13.1.4. Checkpoint Inhibitors

13.1.5. Interleukins

13.1.6. Others

13.2. Therapy Area Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Autoimmune & Inflammatory Diseases

13.2.2. Cancer

13.2.3. Infectious Diseases

13.2.4. Others       

13.3. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.3.1. Hospitals/Clinics

13.3.2. Cancer Research Centers

13.3.3. Others

13.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Saudi Arabia

13.4.4. Turkey

13.4.5. Rest of MEA

13.5. Middle East and Africa Immunotherapy Drugs Market – Opportunity Analysis Index, By Drugs, By Therapy Area, By End User, and Country, 2019 – 2025

13.6. Middle East and Africa Immunotherapy Drugs Market Dynamics – Trends

  1. Competition Landscape

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)

14.2.1. AbbVie Inc

14.2.2. Amgen Inc

14.2.3. AstraZeneca

14.2.4. Bristol-Myers Squibb

14.2.5. F. Hoffmann-La Roche AG

14.2.6.  GlaxoSmithKline plc

14.2.7. Johnson & Johnson

14.2.8. Merck & Co., Inc

14.2.9. Novartis AG

14.2.10. Eli Lilly & Co.   

  1. Research Methodology
  2. Key Assumptions and Acronyms
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials